New Delhi, 15 March 2024: India’s Zydus Lifesciences on Wednesday announced its launch of a generic version of an anti-cancer medicine called olaparib that the company said would be available to patients at a fraction of the cost of the original innovator molecule.

......
View Details

Related News

• Health department orders to recall batch of ‘spurious Telma AM 40’ used for hypertension (12-03-2025)

---

• Zydus Life inks pact to acquire majority stake in Amplitude Surgical (12-03-2025)

---

• Steps taken to prioritize Research on Fungal Infections (12-03-2025)

---

• 1500 Pregabalin capsules seized from four places, four accused arrested (12-03-2025)

---

• India ranked 11th in global pharma exports in 2023: Anupriya Patel (12-03-2025)

---

• ED arrests 2 from Lucknow for shipping 'banned' drugs to US clients (12-03-2025)

---

• Scientists claim major breakthrough in developing vaccine for stroke and heart attack (12-03-2025)

---

• Extortion Racket at Ayurvedic Center Busted: Three Arrested (11-03-2025)

---

• Assam: One held in Cachar with 98,000 Yaba tablets worth Rs 30 crore (11-03-2025)

---

• CCRH and Adamas University Sign MoU to Advance Homoeopathy Research (11-03-2025)

---